Researchers report regenerative effects of low-dose growth factors for bone defect healing

July 27, 2017, Mary Ann Liebert, Inc
Credit: Mary Ann Liebert, Inc., publishers

Researchers compared the effects of three bone growth factors to bone morphogenetic protein 2 (BMP2)—the most commonly used agent for repair of large bone defects, which is not without risks at the doses required—and showed significant bone-healing effects including the formation of new blood vessels at low doses relative to BMP2. These findings, which suggest that the osteogenic factors Nell-1, HMGB1, and CCN2 could enhance bone defect repair using biomaterials, without the need to harvest patient tissue, are reported in Tissue Engineering, Part A.

The article entitled "Nell-1, HMGB1 and CCN2 Enhance Migration and Vasculogenesis, But Not Osteogenic Differentiation Compared to BMP2" is coauthored by Shorouk Fahmy-Garcia, Marjolein van Driel, Janneke Witte-Buoma, Johannes van Leeuwen, Gerjo van Osch, and Eric Farrell, Erasmus Medical Center, Rotterdam, The Netherlends, and Heike Walled, University Hospital Würzburg, Germany. In this study, the researchers directly compared the proteins BMP2, Nell-1, CCN2, and HMGB1 for their ability to recruit endothelial to the site of repair, promote the differentiation of two types of progenitor cells ( and fetal osteoblasts) into mature cells, and induce the formation of new blood vessels.

"The magnification of our understanding of best growth factor choices for bone repair-including the optimization of dosing to prevent side effects-is adding considerably to our capacity to control outcomes in bone engineering," says Tissue Engineering Co-Editor-in-Chief Peter C. Johnson, MD, Principal, MedSurgPI, LLC and President and CEO, Scintellix, LLC, Raleigh, NC.

Explore further: Protein combination improves bone regeneration, study shows

More information: Shorouk Fahmy-Garcia et al, Nell-1, HMGB1 and CCN2 enhance migration and vasculogenesis, but not osteogenic differentiation compared to BMP2, Tissue Engineering Part A (2017). DOI: 10.1089/ten.TEA.2016.0537

Related Stories

Protein combination improves bone regeneration, study shows

January 28, 2016
A UCLA research team has found a combination of proteins that could significantly improve clinical bone restoration. The findings may be a big step toward developing effective therapeutic treatments for bone skeletal defects, ...

New strategy aims to enhance efficacy and safety of bone repair treatment

January 6, 2016
Bone morphogenetic protein-2 (BMP2) is used clinically to promote bone repair. However, the high BMP2 concentrations required to stimulate bone growth in humans may produce life-threatening adverse effects such as cervical ...

Researchers engineer 3-D hydrogels for tissue-specific cartilage repair

July 26, 2017
Unlike the one-size-fits-all, homogeneous approach to tissue engineering for cartilage replacement, a new study reports the ability to encapsulate cartilage-forming chondrocytes and mesenchymal stem cells in 3D hydrogels ...

New study compares bone-inducing properties of 3-D-printed mineralized scaffolds

February 13, 2017
A new study of bone formation from stem cells seeded on 3D-printed bioactive scaffolds combined with different mineral additives showed that some of the scaffold mineral composites induced bone-forming activity better than ...

3-D-printed bioabsorbable scaffold for ACL reconstruction with bone regeneration

February 27, 2017
Researchers have designed a 3D-printed porous scaffold for use in reconstructing ruptured anterior cruciate ligaments (ACL) in the knee and engineered it to deliver a human bone-promoting protein over an extended period of ...

New gene therapy for pseudarthrosis trialed at Kazan University

December 5, 2016
A team headed by Professor Albert Rizvanov, director of the Gene and Cell Technologies Open Lab, has created a gene therapy drug that encodes growth factors for the stimulation of blood vessel and bone formation. The combination ...

Recommended for you

Human 'chimeric' cells restore crucial protein in Duchenne muscular dystrophy

March 16, 2018
Cells made by fusing a normal human muscle cell with a muscle cell from a person with Duchenne muscular dystrophy —a rare but fatal form of muscular dystrophy—were able to significantly improve muscle function when implanted ...

Team develops 3-D tissue model of a developing human heart

March 16, 2018
The heart is the first organ to develop in the womb and the first cause of concern for many parents.

Democratizing science: Researchers make neuroscience experiments easier to share, reproduce

March 16, 2018
Over the past few years, scientists have faced a problem: They often cannot reproduce the results of experiments done by themselves or their peers.

Genetic variant discovery to help asthma sufferers

March 16, 2018
Research from the University of Liverpool, published today in Lancet Respiratory Medicine, identifies a genetic variant that could improve the safety and effectiveness of corticosteroids, drugs that are used to treat a range ...

Researchers say use of artificial intelligence in medicine raises ethical questions

March 15, 2018
In a perspective piece, Stanford researchers discuss the ethical implications of using machine-learning tools in making health care decisions for patients.

Study identifies potential drug for treatment of debilitating inherited neurological disease

March 15, 2018
St. Jude Children's Research Hospital scientists have demonstrated in mouse studies that the neurological disease spinal bulbar muscular atrophy (SBMA) can be successfully treated with drugs. The finding paves the way for ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.